Trial NCT00049088

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02508
Secondary IDs: CDR0000257807 J0203 U01CA070095

Last trial update was posted on 2013-01-24

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Docetaxel Immunoglobulins

MeSH Conditions

Neoplasms

Other Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID